A kind of solid oral preparation containing montelukast sodium and preparation method thereof

A technology of montelukast sodium and oral preparations, which is applied in the field of solid oral preparations containing montelukast sodium and its preparation, and can solve the problem of poor wet stability, sensitivity, and inability to fundamentally solve the stability of montelukast sodium problems and other problems, to achieve the effects of improved stability, less auxiliary material consumption, and simple preparation process

Inactive Publication Date: 2017-09-22
曲素欣
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As for the problem of sensitivity to light, the existing technology is to add sunscreen to solve the problem of sensitivity to light; for the problem of poor moisture stability, the solution of the prior art is to pack moisture-proof clothing or more stringent packaging conditions and packaging form
However, no matter what kind of auxiliary material is added in the tablet, it can only improve its stability to a certain extent, and cannot fundamentally solve the stability problem of montelukast sodium

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of solid oral preparation containing montelukast sodium and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Montelukast Sodium 10g

[0029] 100g pregelatinized starch

[0030] Sucrose Fatty Acid Ester 4g

[0031] Preparation Process:

[0032] Grind montelukast sodium through an 80-mesh sieve, and set aside; dry the pregelatinized starch at 105°C, airtightly let it cool, and set aside; weigh the amount of montelukast sodium, pregelatinized starch, and sucrose fatty acid ester and mix evenly , Φ6.5mm shallow arc stamping sheet, that is. After testing, the initial moisture content of the tablet was 0.91%.

Embodiment 2

[0034] Montelukast Sodium 10g

[0035] 200g pregelatinized starch

[0036] Sucrose Fatty Acid Ester 11g

[0037] Preparation Process:

[0038]Grind montelukast sodium through an 80-mesh sieve, and set aside; dry the pregelatinized starch at 105°C, airtightly let it cool, and set aside; weigh the amount of montelukast sodium, pregelatinized starch, and sucrose fatty acid ester and mix evenly , Φ9mm shallow arc stamping sheet, that is. After testing, the initial moisture content of the tablet was 0.42%.

Embodiment 3

[0040] Montelukast Sodium 10g

[0041] 300g pregelatinized starch

[0042] Sucrose Fatty Acid Ester 20g

[0043] Preparation Process:

[0044] Grind montelukast sodium through an 80-mesh sieve, and set aside; dry the pregelatinized starch at 105°C, airtightly let it cool, and set aside; weigh the amount of montelukast sodium, pregelatinized starch, and sucrose fatty acid ester and mix evenly , Φ10mm shallow arc stamping sheet, that is. After testing, the initial moisture content of the tablet was 0.59%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a solid oral preparation containing montelukast sodium and a preparation method thereof. The preparation is prepared by pulverizing and sieving montelukast sodium, and mixing uniformly with dried pregelatinized starch and sucrose fatty acid ester , ready to be pressed into tablets. Compared with the prior art, the invention has the advantages of less auxiliary material consumption and simple preparation process, and at the same time, the stability of the montelukast sodium tablet is better improved.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a solid preparation of western medicine, in particular to a solid oral preparation containing montelukast sodium and a preparation method thereof. Background technique [0002] Montelukast Sodium is a white or off-white powder with hygroscopic properties, easily soluble in ethanol, methanol, and water, and almost insoluble in acetonitrile. Its chemical name is [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinoline) vinyl]phenyl-3-[2-(1-hydroxy -1-Methylethyl)phenyl]propyl]sulfur]methyl]cyclopropane sodium acetate, molecular formula C 35 h 35 CINNaO 3 S, molecular weight 608.1, structural formula: [0003] [0004] Montelukast sodium is the sodium salt of Montelukast. Due to its unique chemical structure, its oral bioavailability, clinical efficacy and safety are superior to previous similar drugs, and it is currently the best-selling asthma drug in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/404A61K47/26A61K47/36A61P11/06
Inventor 曲素欣
Owner 曲素欣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap